Results 11 to 20 of about 3,018 (196)
Generalized Papulosquamous Skin Eruption in a Teenager After COVID‐19 Booster
Reports of pityriasis rubra pilaris (PRP) occurring after COVID‐19 vaccination continue to emerge, thus it is important to maintain a high index of suspicion for PRP in patients with new‐onset cutaneous symptoms postvaccination.
Alice J. Lin +2 more
doaj +2 more sources
Plantar Lichen Planus is a rare and often underrecognized variant of Lichen Planus that can mimic pityriasis rubra pilaris and psoriasis clinically. Accurate diagnosis relies on clinicopathological correlation, and a high index of suspicion is essential ...
Shraddha Uprety +3 more
doaj +2 more sources
A case of paraneoplastic pityriasis rubra pilaris [PDF]
Nina Mehta, BS +4 more
doaj +2 more sources
Rethinking pityriasis rubra pilaris as a paraneoplastic syndrome: Two cases of pityriasis rubra pilaris with concomitant underlying malignancy [PDF]
Anna E. Davis, BS +4 more
doaj +2 more sources
Refractory pityriasis rubra pilaris treated with upadacitinib [PDF]
Eingun James Song, MD +2 more
doaj +2 more sources
Background Pityriasis rubra pilaris (PRP) is a rare and often severe inflammatory skin disorder with major detriment to patients' quality of life. While past studies have described in detail the morphologic and histopathologic presentations of PRP ...
Rose C. Velasco +3 more
doaj +1 more source
Pityriasis Rubra Pilar and hypothyroidism [PDF]
Pityriasis Rubra Pilaris (PRP) is a chronic and rare papulosquamous disorder. Treatment of Pityriasis Rubra Pilaris is based on empiric evidence because of several doubts regarding its etiology and also because of its relative rarity, making randomized ...
Aline Martinez Franzotti +4 more
doaj +2 more sources
Classic adult pityriasis rubra pilaris is a severe papulosquamous disease that tends to resolve in 3–5 years but can have a devastating impact on patients while active.
Celina DeBiasio +3 more
doaj +1 more source
Ixekizumab successfully treated severe pityriasis rubra pilaris after COVID‐19 vaccination
Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause. We report a 67‐year‐old man with Pityriasis rubra pilaris might induced by COVID‐19 vaccination.
Ya‐ting Liu, Shang‐shang Wang
doaj +1 more source
Acral pityriasis rubra pilaris [PDF]
A previously healthy 34-year-old woman presented to her family physician with an asymptomatic erythematous rash on her hands that had been present for several weeks. She had elevated levels of alanine transaminase, alkaline phosphatase and γ-glutamyltransferase, compatible with a diagnosis ...
Michael, Sander, Megan, Sander
openaire +2 more sources

